Cibus (CBUS) Competitors $2.49 -0.06 (-2.35%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$2.49 0.00 (0.00%) As of 01/31/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CBUS vs. ARQ, LNZA, ADUR, ORGN, TSE, ALTO, ZTEK, VGAS, AMTX, and LODEShould you be buying Cibus stock or one of its competitors? The main competitors of Cibus include ARQ (ARQ), LanzaTech Global (LNZA), Aduro Clean Technologies (ADUR), Origin Materials (ORGN), Trinseo (TSE), Alto Ingredients (ALTO), Zentek (ZTEK), Verde Clean Fuels (VGAS), Aemetis (AMTX), and Comstock (LODE). These companies are all part of the "chemicals" industry. Cibus vs. ARQ LanzaTech Global Aduro Clean Technologies Origin Materials Trinseo Alto Ingredients Zentek Verde Clean Fuels Aemetis Comstock ARQ (NASDAQ:ARQ) and Cibus (NASDAQ:CBUS) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk. Does the media refer more to ARQ or CBUS? In the previous week, Cibus had 4 more articles in the media than ARQ. MarketBeat recorded 7 mentions for Cibus and 3 mentions for ARQ. ARQ's average media sentiment score of 0.49 beat Cibus' score of -0.24 indicating that ARQ is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ARQ 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cibus 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, ARQ or CBUS? ARQ has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Comparatively, Cibus has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Do analysts prefer ARQ or CBUS? ARQ currently has a consensus price target of $10.00, indicating a potential upside of 60.26%. Cibus has a consensus price target of $22.17, indicating a potential upside of 790.23%. Given Cibus' stronger consensus rating and higher probable upside, analysts clearly believe Cibus is more favorable than ARQ.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ARQ 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cibus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Which has preferable earnings & valuation, ARQ or CBUS? ARQ has higher revenue and earnings than Cibus. ARQ is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioARQ$99.18M2.64-$12.25M-$0.01-624.00Cibus$1.82M36.20-$267.64M-$22.48-0.11 Does the MarketBeat Community favor ARQ or CBUS? Cibus received 10 more outperform votes than ARQ when rated by MarketBeat users. Likewise, 100.00% of users gave Cibus an outperform vote while only 66.67% of users gave ARQ an outperform vote. CompanyUnderperformOutperformARQOutperform Votes266.67% Underperform Votes133.33% CibusOutperform Votes12100.00% Underperform VotesNo Votes Do institutionals and insiders believe in ARQ or CBUS? 18.5% of ARQ shares are held by institutional investors. Comparatively, 33.8% of Cibus shares are held by institutional investors. 26.9% of ARQ shares are held by insiders. Comparatively, 49.4% of Cibus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is ARQ or CBUS more profitable? ARQ has a net margin of -0.44% compared to Cibus' net margin of -10,724.78%. ARQ's return on equity of -0.25% beat Cibus' return on equity.Company Net Margins Return on Equity Return on Assets ARQ-0.44% -0.25% -0.19% Cibus -10,724.78%-28.17%-13.39% SummaryCibus beats ARQ on 12 of the 19 factors compared between the two stocks. Get Cibus News Delivered to You Automatically Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBUS vs. The Competition Export to ExcelMetricCibusAgricultural chemicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$64.29M$5.02B$16.07B$9.11BDividend YieldN/A3.16%2.82%3.99%P/E Ratio-0.1145.2021.3018.28Price / Sales36.208.793.8280.65Price / Cash0.317.7817.4537.70Price / Book0.200.996.204.70Net Income-$267.64M$340.44M$608.39M$224.47M7 Day Performance2.89%0.77%0.15%-0.20%1 Month Performance-10.43%39.35%2.11%0.57%1 Year Performance-85.57%-28.11%7.74%20.29% Cibus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBUSCibus2.4743 of 5 stars$2.49-2.4%$22.17+790.2%-85.1%$64.29M$1.82M-0.1148Short Interest ↑Gap DownARQARQ2.379 of 5 stars$6.21-3.3%$10.00+61.0%N/A$261.01M$99.18M-621.00140Short Interest ↑LNZALanzaTech Global1.7413 of 5 stars$1.05-9.5%$4.00+282.8%-78.4%$206.66M$62.63M-1.613ADURAduro Clean TechnologiesN/A$5.68+0.4%N/AN/A$161.54MN/A0.00N/ANews CoverageORGNOrigin Materials1.5869 of 5 stars$1.00-2.0%$1.50+50.0%+58.5%$146.25M$28.81M-1.75160Short Interest ↑TSETrinseo0.3806 of 5 stars$4.04-4.0%N/A-31.3%$143.05M$3.68B-0.293,100Short Interest ↑News CoveragePositive NewsALTOAlto Ingredients3.2884 of 5 stars$1.71+2.4%$5.50+221.6%-11.4%$131.07M$1.22B-3.29420Short Interest ↓News CoverageZTEKZentek0.734 of 5 stars$1.14-2.6%N/A-18.2%$118.68M$39,356.00-14.2524Short Interest ↓News CoverageGap DownVGASVerde Clean Fuels0.0451 of 5 stars$3.52-1.1%N/A+38.3%$112.82MN/A-7.042Short Interest ↑News CoverageAMTXAemetis1.9358 of 5 stars$2.19+0.5%$12.95+491.3%-36.5%$108.93M$186.72M-0.97160LODEComstock1.6153 of 5 stars$0.36-6.1%$2.60+628.7%-18.4%$83.88M$1.27M-2.9730News CoverageGap Up Related Companies and Tools Related Companies ARQ Alternatives LNZA Alternatives ADUR Alternatives ORGN Alternatives TSE Alternatives ALTO Alternatives ZTEK Alternatives VGAS Alternatives AMTX Alternatives LODE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBUS) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.